Oragenics Touts New Drug to Fight Clostridium Difficile (Proactive Investors)
New research by Sid Martin Biotech alum Oragenics Inc., now a Tampa-based clinical-stage biotech group, has uncovered a novel type of antibiotic known as a... Read More
Want our news in your inbox every Monday morning? You can!